A Country That Exports Its Own Advantage

In March 2024, the Senior Deputy Governor of the Bank of Canada, Carolyn Rogers, gave a speech with an unusually blunt title: it was time to “break the glass” on Canada’s productivity emergency. A central bank does not use the word emergency lightly [1] . Her figures were stark: Canadian productivity had fallen to roughly 71 percent of the US level, down from about 88 percent in the mid-1980s. Business investment per worker had lagged the United States for decades. The country’s output per hour had barely moved in years.

You have probably heard some version of this before, usually framed as a puzzle. Canada has excellent universities, a skilled workforce, public research funding, and a stable society. So why does it consistently underperform on the outcomes that matter: companies scaled, patents owned, wages grown, industries built?

The answer is not a shortage of talent or ideas. It is a set of structural gaps between what Canada creates and what Canada keeps. My doctoral research names five of them. Each is documented by Canada’s own institutions. This essay lays out the problem. It withholds the prescription, because the prescription has since grown into work I am now building, and the problem deserves to be seen clearly on its own terms first.

Gap One: Commercialization and Scale-Up

Canada is strong at the early stages of discovery and weak at turning discovery into companies that scale. The Council of Canadian Academies, in its 2025 assessment of the country’s innovation performance, put it plainly: Canada excels in research but falls short when it comes to retaining the value of its innovations [2] .

The investment data underneath that judgement is not encouraging. Canada’s gross expenditure on research and development sat at 1.81 percent of GDP in 2022, against an OECD average of 2.73 percent, and the Canadian figure has been falling while peer countries rise. Business R&D is where the shortfall concentrates [3] . A country that under-invests in development, the D in R&D, should not be surprised when its research does not become products.

Gap Two: Talent Retention

Canada educates world-class people and then watches a meaningful share of them leave, most often for the United States. The single hardest number to look at comes from US government records. Under the CUSMA professional-worker provisions, a Canadian engineer, scientist, accountant, lawyer, or nurse can cross the border to work with a job offer and a single interview. In US fiscal year 2023, Canadians used that pathway more than 1.2 million times. This counts admissions (border entries), not unique individuals, so a frequent commuter is counted many times; even so, it is the clearest signal we have of the scale of professional movement south [4] .

The mechanism is not mysterious. It is a compensation and opportunity gap : higher salaries, more scale-stage companies, deeper capital. Canada pays to train the talent. Another country captures the return on that investment.

Gap Three: IP Ownership

Even when Canadian research does become valuable intellectual property, the ownership often ends up elsewhere. The Council of Canadian Academies flagged persistent barriers in retaining intellectual property [5] among the country’s systemic weaknesses.

The structural context is a highly foreign-controlled economy in key sectors. Statistics Canada reported that foreign-controlled firms held 44.3 percent of manufacturing assets and 48.2 percent of wholesale-trade assets in 2021 [6] . Ownership determines where the durable upside of an innovation accrues: the licensing rents, the strategic control, the next generation of R&D built on top. When the ownership sits abroad, so does the compounding.

A caution worth stating: foreign investment is not inherently harmful, and the asset-control figures are not a direct measure of patent ownership. They describe the terrain on which Canadian IP is developed and, too often, absorbed.

Gap Four: Strategic Vision and Coordination

The three gaps above are made worse by a fourth: the absence of a coherent national vision that aligns capital, talent, and policy toward shared goals. The Council of Canadian Academies described Canada’s innovation system as a highly fragmented system requiring a coordinated and wide-ranging overhaul [7] .

Fragmentation is expensive in ways that do not appear on any single ledger. Programs duplicate one another. Founders navigate a maze of agencies. No shared direction tells a researcher in Halifax, an investor in Toronto, and a policymaker in Ottawa that they are building the same thing. The result is motion without momentum.

Gap Five: Long-Term Investment and Risk Aversion

The fifth gap is cultural and financial: a preference for the near, the safe, and the liquid over the long, the uncertain, and the sovereign. Rogers’ productivity speech returned repeatedly to under-investment: Canadian business has invested less per worker than its American counterpart for a very long time, and recent investment levels have been lower than they were a decade ago [8] .

Patient capital, the kind that funds a hard technology or a sovereign industry over fifteen or thirty years, is exactly what a country needs to close the first four gaps. It is also the kind Canada’s system is least structured to supply.

The Gaps Compound

Read separately, each gap is a known problem with a literature and a lobby. Read together, they form a single machine that converts Canadian advantage into value captured elsewhere.

GapWhat leaksWhere the value goes
CommercializationResearch that never scalesForeign scale-ups, or nowhere
Talent retentionSkilled graduates and professionalsMostly the United States
IP ownershipPatents, licences, controlForeign-controlled firms
CoordinationAligned national effortDissipated across fragmented programs
Long-term investmentPatient, sovereign capitalShort-horizon, liquid, safe bets

A researcher is trained on public funding (a cost Canada bears), makes a discovery that struggles to commercialize at home (Gap 1), takes a US job because the opportunity is larger (Gap 2), and the resulting IP is owned by a foreign employer (Gap 3), because no coordinated national vision offered a domestic alternative (Gap 4) and no patient capital was there to fund one (Gap 5). Five gaps, one leak.

The Part I Am Leaving Open

There is a version of this essay that ends with a five-point plan. I am not writing that version here, for two reasons.

The first is intellectual honesty. Naming a problem well is a different act from solving it, and collapsing the two tempts a reader to accept a prescription because the diagnosis felt right. The diagnosis should stand on the evidence: the Bank of Canada, Statistics Canada, and the Council of Canadian Academies, not on the appeal of whatever comes next.

The second is that the prescription has outgrown the essay. What began, in my 2025 doctoral proposal, as a framework for foresight-driven innovation has since become something I am building rather than writing about. That work deserves its own account, on its own evidence, when it has results to show.

For now, the question worth sitting with is the uncomfortable one underneath all five gaps: Canada holds enormous latent potential, and potential that is not actualized at home does not simply wait. It leaves. The open question is whether a country can decide to keep what it makes, and what it would have to build to do so.